Biotech News

MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29

MiMedx (MDXG)MiMedxEarnings

MARIETTA, Ga., July 20, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30, 2026 after the market close on Wednesday, July 29, 2026. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.

The conference call can be accessed using the following information:

Webcast: Click here U.S. Investors: 877-407-6184 International Investors: 201-389-0877 Conference ID: 13761338

A replay of the webcast will be available for approximately 30 days on the Company’s website at www.mimedx.com following the conclusion of the event.

About MIMEDX MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade and a half of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX provides a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com .

Contact: Matt Notarianni Investor Relations 470-304-7291 mnotarianni@mimedx.com

Open original release

Related news

MiMedx

MiMedx is a regenerative medicine company focused on placental biologics and tissue-based products used in wound care and surgical settings. The company’s story is more about biologic products than classic biotech development.

Recent company news

Stock data

Close
4.26 USD
Market cap
531.74M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States